This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: EXPE, WAG, UAL, RE

NEW YORK ( TheStreet) --


Baxter International (BAX) is upgraded to buy at TheStreet Ratings.

Brinker (EAT - Get Report) numbers raised at UBS. Shares of EAT now seen reaching $30. Estimates also increased on positive SSS. Buy rating.

Expedia (EXPE - Get Report) numbers raised at UBS. Shares of EXPE now seen reaching $33. Estimates also increased after TipAdvisor spin off. Neutral rating.

Mead Johnson Nutrition (MJN - Get Report) numbers lowered at Goldman Sachs. Shares of MJN now seen reaching $74. Estimates also lowered on product safety fears. Neutral rating.

Everest Re (RE - Get Report) numbers lowered at UBS. Shares of RE now seen reaching $105. Estimates also lowered on Thailand floods. Buy rating.

Salix Pharmaceuticals numbers raised at Goldman Sachs. Shares of SLXP now seen reaching $46. Estimates also raised on positive Phase III data. Neutral rating.

United Continental (UAL - Get Report) estimates lowered at UBS through 2012. Company guides down. Buy rating and $35 price target.

Walgreen (WAG) numbers lowered at Jefferies. Shares of WAG now seen reaching $34. Estimates also lowered on ongoing uncertainty surrounding the ESRX contract. Hold rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
EAT $46.32 -0.96%
EXPE $114.11 -1.60%
MJN $84.87 -0.26%
SLXP $172.81 0.09%
RE $182.75 -1.06%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs